Form 8-K - Current report:
SEC Accession No. 0001193125-25-145830
Filing Date
2025-06-24
Accepted
2025-06-24 17:27:03
Documents
12
Period of Report
2025-06-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d909229d8k.htm   iXBRL 8-K 31398
  Complete submission text file 0001193125-25-145830.txt   145509

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idya-20250624.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20250624_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20250624_pre.xml EX-101.PRE 11265
14 EXTRACTED XBRL INSTANCE DOCUMENT d909229d8k_htm.xml XML 3652
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 251070232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)